Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Kaat Durinck

Results : ALL ( 11 )

As Promotor

01 January 2022 → 31 December 2025

Building a next-generation precision oncology platform for childhood cancer

Funding: Regional and community funding: Special Research Fund

01 September 2021 → 31 August 2026

Tenure track professorship in pediatric precision oncology

Fellow: Kaat Durinck

Funding: Regional and community funding: Special Research Fund

As Copromotor

01 November 2020 → 31 October 2024

The dual role PSIP1 in T-cell acute lymphoblastic leukemia (T-ALL)

Fellow: Lisa Demoen

Funding: Research Foundation - Flanders (FWO)

01 October 2019 → 30 July 2024

The PHF6 - TLX1 cooperativity and the IL7R-JAK3 signaling axis as drug target in PHF6 deficient TALL.

Funding: Regional and community funding: Special Research Fund

As Fellow

01 September 2021 → 31 August 2026

Tenure track professorship in pediatric precision oncology

Fellow: Kaat Durinck

Funding: Regional and community funding: Special Research Fund

01 October 2018 → 31 August 2021

The role of BRCA1 as oncogenic replicative stress resistor in MYCN driven neuroblastoma

Fellow: Kaat Durinck

Funding: Research Foundation - Flanders (FWO)

01 January 2018 → 31 December 2018

The chromatin modifier BRD3 as a key novel player in DNA repair and vulnerable therapeutic target in neuroblastoma

Fellows: Kaat Durinck

Funding: Research Foundation - Flanders (FWO)

01 October 2016 → 30 September 2019

Identification of novel therapeutic targets through multi-level (epi) genomic landscaping of replicative stress resistant neuroblastoma

Fellows: Kaat Durinck

Funding: Regional and community funding: Special Research Fund

01 January 2015 → 31 December 2015

The PHF6 - TLX1 cooperativity and the IL7R-JAK3 signaling axis as drug target in PHF6 deficient T-ALL

Fellow: Kaat Durinck

Funding: Research Foundation - Flanders (FWO)

01 October 2010 → 05 January 2016

Unraveling the role of PHF6 in normal T cell development and T-cell acute lymphoblastic leukemia

Fellow: Kaat Durinck

Funding: Regional and community funding: IWT/VLAIO

As Contact person

01 January 2022 → 31 December 2025

Building a next-generation precision oncology platform for childhood cancer

Funding: Regional and community funding: Special Research Fund